Testing effectiveness (Phase 2)Study completedNCT01720875What this trial is testingVorinostat, Bortezomib and Dexamethasone in Multiple Myeloma (MUKFour)Who this might be right forMultiple Myeloma University of Leeds 16
Not applicableNo Longer AvailableNCT02368301What this trial is testingExpanded Access Treatment Protocol CA204-143Who this might be right forMultiple Myeloma Bristol-Myers Squibb
Testing effectiveness (Phase 2)Study completedNCT02581007What this trial is testingReduced Intensity Conditioning Transplant Using Haploidentical DonorsWho this might be right forChronic Myelogenous LeukemiaAcute Myelogenous LeukemiaMyelodysplastic Syndrome+7 more Northside Hospital, Inc. 25
Not applicableStudy completedNCT05849792What this trial is testingInternet-based Physical Activities Randomized Controlled Trial in Mild/Moderate Depression Participants: SONRIE ProjectWho this might be right forExercisePhysical FitnessDepression+2 more University of Cadiz 80
Not applicableStudy completedNCT04000711What this trial is testingSafety and Efficacy of Ambulatory Versus In-hospital Antibiotic Treatment in Children With Febrile NeutropeniaWho this might be right forChemotherapy-Induced Febrile Neutropenia Hospital Infantil de Mexico Federico Gomez 117
Not applicableNo Longer AvailableNCT00413270What this trial is testingOral Nilotinib in Adults With Chronic Myeloid Leukemia (CML) in Blast Crisis Who Are Imatinib Resistant or IntolerantWho this might be right forChronic Myelogenous Leukemia Novartis Pharmaceuticals
Post-approval studies (Phase 4)Study completedNCT01061177What this trial is testingNilotinib in Newly Diagnosed Adult Philadelphia Chromosome & /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic PhaseWho this might be right forCML in Chronic Phase Novartis Pharmaceuticals 1,090
Not applicableActive Not RecruitingNCT05709912What this trial is testingMobile CARE-App to Promote Coping for Caregivers of Patients Receiving Stem Cell TransplantWho this might be right forBone Marrow Transplant ComplicationsHematologic Malignancy Massachusetts General Hospital 120
Testing effectiveness (Phase 2)Study completedNCT02113319What this trial is testingStudy to Assess Dasatinib in Patients With Core Binding Factors Acute Myelogenous LeukemiaWho this might be right forAcute Myelogenous Leukemia University Hospital, Angers 27
Testing effectiveness (Phase 2)UnknownNCT05054465What this trial is testingA Phase 1b-2 Trial to Assess Venetoclax and Navitoclax Consolidation and Post-transplant Maintenance in High-risk Patients With T-ALLWho this might be right forAcute Lymphoblastic Leukemia Israeli Medical Association 48
Not applicableEnded earlyNCT02276651What this trial is testingObservational Trial of a Therapeutic Platelet Transfusion RegimenWho this might be right forAcute Myeloid LeukemiaThrombocytopenia Klinikum Nürnberg 25
Not applicableStudy completedNCT02830477What this trial is testingStudy Evaluating "Real World" Treatment Pattern in Previously Treated Hemophilia A Patients Receiving KOVALTRY (Octocog Alfa) for Routine ProphylaxisWho this might be right forHemophilia A, Congenital Bayer 313
Not applicableLooking for participantsNCT03735992What this trial is testingMind-body Medicine for Patients With Malignant Hematological DiseasesWho this might be right forHematologic Neoplasms Universität Duisburg-Essen 94
Testing effectiveness (Phase 2)Looking for participantsNCT04047641What this trial is testingCladribine, Idarubicin, Cytarabine, and Quizartinib in Treating Patients With Newly Diagnosed, Relapsed, or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic SyndromeWho this might be right forAcute Myeloid LeukemiaBlasts 20 Percent or More of Bone Marrow Nucleated CellsHigh Risk Myelodysplastic Syndrome+5 more M.D. Anderson Cancer Center 80
Large-scale testing (Phase 3)UnknownNCT01532856What this trial is testingIberoamerican Protocol With Thalidomide in Patients With Symptomatic Newly Diagnosed Multiple Myeloma Over 65 YearsWho this might be right forMultiple Myeloma Grupo de Estudos Multicentricos em Onco-Hematologia 64
Testing effectiveness (Phase 2)UnknownNCT00247039What this trial is testingGarlic in Patients With Febrile NeutropeniaWho this might be right forChemotherapyNeutropenia Hadassah Medical Organization 120
Early research (Phase 1)Study completedNCT00012207What this trial is testingBiological Therapy After Chemotherapy in Treating Patients With Relapsed or Refractory Non-Hodgkin's LymphomaWho this might be right forLeukemiaLymphoma Fred Hutchinson Cancer Center 12
Not applicableStudy completedNCT03793907What this trial is testingStrength Training in Improving Pain and Quality of Life in Patients With Multiple MyelomaWho this might be right forPlasma Cell Myeloma Roswell Park Cancer Institute 65
Early research (Phase 1)Looking for participantsNCT06378437What this trial is testingGLB-001 in Patients With Myeloid MalignanciesWho this might be right forPolycythemia VeraEssential ThrombocythemiaMyelofibrosis+3 more Hangzhou GluBio Pharmaceutical Co., Ltd. 108
Not applicableWithdrawnNCT03138395What this trial is testingICare3: Monitoring Circulating Cancer DNA After Chemotherapy in MDS and AMLWho this might be right forAcute LeukemiaMyelodysplastic SyndromesAML+1 more University of Florida